Roman Perkowski

Roman Perkowski

Roman Perkowski is a senior markets reporter at TS2.tech. His coverage ranges from stocks and technology to economic developments across global markets. He graduated from the Cracow University of Economics and worked in investment research and corporate finance before becoming a financial journalist. Follow Roman Perkowski on Google News.

AbbVie moves to acquire Apogee in $10.9 billion bet on immunology

AbbVie moves to acquire Apogee in $10.9 billion bet on immunology

AbbVie said Monday it’s buying Apogee Therapeutics for $10.9 billion in cash, making this its largest deal since 2019. The company is looking to strengthen its immunology pipeline with Apogee’s long-acting immune-disease drugs. AbbVie and Apogee put out a joint release on the agreement, according to a securities filing. They expect the deal to close in the third quarter of 2026.
Intel (NASDAQ: INTC) Gets an Apple Premium, Math Shows Little Room Left

Intel (NASDAQ: INTC) Gets an Apple Premium, Math Shows Little Room Left

Intel Corporation is in focus Monday after jumping 10.64% to $133.99 last session. Early premarket quotes put the stock at $139.64, up 4.2% from that close. The gain comes after President Donald Trump said Apple would partner with Intel to design and make chips in the U.S. Reuters said Apple and Intel haven’t commented yet. For now, shares are trading up, with the deal details not out.
Walmart’s Hawaiian Roll Recall Linked to Wrapper, Not Bread

Walmart’s Hawaiian Roll Recall Linked to Wrapper, Not Bread

Walmart’s Great Value Hawaiian Roll four-packs are now included in a new FDA recall. United States Bakery, based in Oregon, reported an oily, sticky substance on the direct food-contact packaging. The recall covers 10,447 cases sent to 26 states. The concern centers on packaging that touches the rolls, not a confirmed problem with the bread itself.
22 June 2026
1 25 26 27 28 29 38